Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients (Q58473870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Mark Atkins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Padraig Strappe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Steve Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Clive Loveday

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

James E. McLaughlin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Margaret A. Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Richard S. Tedder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Paul D. Griffiths

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

June 1998

0 references

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

138-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Redistribution of HIV outside the lymphoid system with onset of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Extrahepatic metabolism of zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

A controlled trial of zidovudine in primary human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Detection of Mutations Associated with Zidovudine Resistance in Human Immunodeficiency Virus by Use of the Polymerase Chain Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199806%2955%3A2%3C138%3A%3AAID-JMV10%3E3.0.CO%3B2-E

10.1002/(SICI)1096-9071(199806)55:2<138::AID-JMV10>3.0.CO;2-E

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9598935%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference